GeneDx has announced the immediate appointment of Bryan Dechairo as Chief Operating Officer. In this newly established position, Dechairo will report directly to CEO and President Katherine Stueland, joining the company's executive leadership team.
As COO, Dechairo will be responsible for overseeing the Product and Technology, Operations, Medical Affairs, Innovation, and Program Management departments at GeneDx. Stueland expressed confidence in Dechairo's qualifications, stating, "Bryan's extensive clinical, technical, and operational expertise, coupled with his proven track record in leading scalable transformations, will be crucial in advancing our strategic goals and promoting the integration of genomic insights within the healthcare sector."
